Noile-Immune Biotech Inc (4893)

Currency in JPY
88.00
+1.00(+1.15%)
Closed·
4893 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
86.0088.00
52 wk Range
85.00217.00
Key Statistics
Bid/Ask
87.00 / 88.00
Prev. Close
88
Open
87
Day's Range
86-88
52 wk Range
85-217
Volume
154.4K
Average Volume (3m)
182.65K
1-Year Change
-46.0123%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4893 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
440.00
Upside
+400.00%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 440.00
(+400.00% Upside)

Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
-5.05 / -5.51
Revenue / Forecast
-- / 2M
EPS Revisions
Last 90 days

4893 Income Statement

Compare 4893 to Peers and Sector

Metrics to compare
4893
Peers
Sector
Relationship
P/E Ratio
−5.1x−5.5x−0.3x
PEG Ratio
0.56−0.160.00
Price/Book
1.1x2.9x2.6x
Price / LTM Sales
3,819.1x19.1x2.8x
Upside (Analyst Target)
-94.8%64.7%
Fair Value Upside
Unlock14.5%9.6%Unlock

Noile-Immune Biotech Inc. researches and develops CAR-T cells for novel cancer immunotherapies. The company’s product pipeline includes, NIB101, a target antigen for solid tumors; NIB102, a next-generation CAR-T cell therapy; NIB103, autologous CAR-T cell therapy for mesothelin (MSLN); NIB104, a PRIME technology against target antigens in solid tumors; ADAP01; AUTL01; and CHUG01. Noile-Immune Biotech Inc. was incorporated in 2015 and is headquartered in Minato, Japan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
11.75M27.07%1.03B
Public Companies & Retail Investors
31.65M72.93%2.79B
Total
43.4M100.00%3.82B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Takeda Ventures, Inc.18.71%8,119,800714,542
DCI Partners Co., Ltd.3.11%1,349,200118,730

FAQ

What Is the Noile-Immune Biotech (4893) Stock Price Today?

The Noile-Immune Biotech stock price today is 88.00 JPY.

What Stock Exchange Does Noile-Immune Biotech Trade On?

Noile-Immune Biotech is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for Noile-Immune Biotech?

The stock symbol for Noile-Immune Biotech is "4893."

What Is the Noile-Immune Biotech Market Cap?

As of today, Noile-Immune Biotech market cap is 3.78B JPY.

What Is Noile-Immune Biotech's Earnings Per Share (TTM)?

The Noile-Immune Biotech EPS (TTM) is -17.41.

When Is the Next Noile-Immune Biotech Earnings Date?

Noile-Immune Biotech will release its next earnings report on Nov 13, 2026.

From a Technical Analysis Perspective, Is 4893 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Noile-Immune Biotech Stock Split?

Noile-Immune Biotech has split 0 times.

How Many Employees Does Noile-Immune Biotech Have?

Noile-Immune Biotech has 23 employees.

What is the current trading status of Noile-Immune Biotech (4893)?

As of Oct 27, 2026, Noile-Immune Biotech (4893) is trading at a price of 88.00 JPY, with a previous close of 88.00 JPY. The stock has fluctuated within a day range of 86.00 JPY to 88.00 JPY, while its 52-week range spans from 85.00 JPY to 217.00 JPY.

What Is Noile-Immune Biotech (4893) Price Target According to Analysts?

The average 12-month price target for Noile-Immune Biotech is 440.00 JPY, with a high estimate of 440 JPY and a low estimate of 440 JPY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +400.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.